Rest

LMBM INC. OPENS NEW RETREAT PROPERTY IN NORTHEAST OHIO

Retrieved on: 
Thursday, August 18, 2022 - 3:12pm

Trilogy Retreat Property is available for booking and touring; to inquire or schedule a visit, contact Aimee Noelle at 833-538-6323 or info@trilogy.center or visit trilogy.center.com.

Key Points: 
  • Trilogy Retreat Property is available for booking and touring; to inquire or schedule a visit, contact Aimee Noelle at 833-538-6323 or info@trilogy.center or visit trilogy.center.com.
  • Let Me Be Ministries (LMBM Inc.), founded in 2009, is a non-profit, 501(c)3 ministry based in Chagrin Falls, Ohio.
  • LMBM extends the message of hope through faith beyond conventional houses of worship with online and in-person events, digital media, published resources, and spiritual direction.
  • Their faith and real-life mission remains to enrich personal growth, encourage community, and help restore the value of family.

Springfield Massachusetts Small Business Owner Expands Critter Control Territory to Cover all of Western Massachusetts

Retrieved on: 
Thursday, August 18, 2022 - 2:30pm

SPRINGFIELD, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Critter Control , an industry leader in the humane removal of nuisance wildlife, announced today that current franchisee, Jonathan Cahoon, is expanding to cover all of Western Massachusetts.

Key Points: 
  • SPRINGFIELD, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Critter Control , an industry leader in the humane removal of nuisance wildlife, announced today that current franchisee, Jonathan Cahoon, is expanding to cover all of Western Massachusetts.
  • Calhoun, who purchased Critter Control franchise in 2021 focused on Springfield, Chicopee, Holyoke and the rest of Hampden County.
  • Prior to joining Critter Control, he worked as a truck driver, servicing Western Massachusetts businesses.
  • Critter Control of Springfield is open Monday through Friday from 8:00am 5:00pm and emergency services available on Saturday and Sunday.

Concourse Financial Group Welcomes Key Group

Retrieved on: 
Thursday, August 18, 2022 - 11:00am

BIRMINGHAM, Ala., Aug. 18, 2022 /PRNewswire/ -- Concourse Financial Group ("Concourse"), a division of Protective Life Corporation ("Protective"), supporting more than 500 independent financial professionals nationwide, today announced the successful recruitment of Key Group Management, Inc. ("Key Group"), a hybrid RIA practice with over $500 million in client assets and nine financial professionals. Key Group Management, Inc. is affiliated with Concourse's FINRA-registered broker-dealer, Concourse Financial Group Securities.

Key Points: 
  • BIRMINGHAM, Ala., Aug. 18, 2022 /PRNewswire/ -- Concourse Financial Group ("Concourse"), a division of Protective Life Corporation ("Protective"), supporting more than 500 independent financial professionals nationwide, today announced the successful recruitment of Key Group Management, Inc. ("Key Group"), a hybrid RIA practice with over $500 million in client assets and nine financial professionals.
  • Key Group Management, Inc. is affiliated with Concourse's FINRA-registered broker-dealer, Concourse Financial Group Securities.
  • Concourse CEO Doyle Williams said, "We are honored to welcome Pat, Colin and the rest of the Key Group team to Concourse Financial Group.
  • Comprised of investment services, financial planning, insurance services and practice management services, Concourse Financial Group is the destination for growth-oriented financial professionals.

Hubilo Prioritizes Customer Data Security and Privacy with AICPA SOC2 Type 2 ® Certification

Retrieved on: 
Wednesday, August 17, 2022 - 8:47pm

SAN FRANCISCO, Aug. 17, 2022 /PRNewswire/ -- Hubilo, the leading virtual, in-person, and hybrid event tech platform, completes its Systems and Organizations Controls audit and certification, demonstrating its commitment to building client trust and confidence in Hubilo's systems. The SOC2 Type 2 ® report recognizes Hubilo's practice of reliable, safe, and trustworthy management of client privacy and data security.

Key Points: 
  • The SOC2 Type 2 report recognizes Hubilo's practice of reliable, safe, and trustworthy management of client privacy and data security.
  • The reporting process outlines five trust service principles of security, availability, processing integrity, confidentiality, and privacy of customer data as a framework for safeguarding data.
  • Hubilo will ensure that they manage to exceed their clients' expectations regarding their data security and privacy requirements and will continue to have the process of external audit/reviews done for SOC2 Type 2 at regular intervals.
  • To learn more about the data security implemented by the SOC2 certification, please visit https://us.aicpa.org/interestareas/frc/assuranceadvisoryservices/aicpaso... .

ELYSIAN Creator-in-Chief Ryan Stalvey Named 2022 Folio: Eddie & Ozzie Awards Designer of the Year

Retrieved on: 
Wednesday, August 17, 2022 - 7:01pm

In addition to Designer of the Year, Stalvey is a finalist for an Ozzie for Overall Art Direction - Consumer/Custom Content Marketing for the magazine's Winter 2021/22, Spring 2022, and Summer 2022 issues.

Key Points: 
  • In addition to Designer of the Year, Stalvey is a finalist for an Ozzie for Overall Art Direction - Consumer/Custom Content Marketing for the magazine's Winter 2021/22, Spring 2022, and Summer 2022 issues.
  • To have Ryan Stalvey named 2022 Designer of the Year is an honor we are immensely proud of," ELYSIAN Publisher Karen Floyd said.
  • The coveted Eddie & Ozzie Awards are to magazines and online publishing what the Academy Awards are to the motion picture industry.
  • "Being recognized as part of the 2022 Folio: Eddie & Ozzie Awards is confirmation from your peers that your work stands out above the rest.

Limitless Guided Visualizations App Provides A Major Breakthrough in Mental Health Support Options

Retrieved on: 
Wednesday, August 17, 2022 - 3:22pm

SAN JOSE, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Limitless Guided Visualizations (Limitless), a mental health and wellness app, announced today its cognitive support product as an up-and-coming contribution to treating the mental health epidemic.

Key Points: 
  • SAN JOSE, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Limitless Guided Visualizations (Limitless), a mental health and wellness app, announced today its cognitive support product as an up-and-coming contribution to treating the mental health epidemic.
  • The Limitless app helps people reflect on their thought processes and reframe the relationship they have with themselves, thus improving their metacognition.
  • Limitless Guided Visualizations is a mental health and wellness app that empowers people to become the champion of their own personal health journeys.
  • The Limitless Guided Visualizationsapp is free to download in the App Store and on Google Play .

ZetrOZ Systems Presented at the Annual PHATS/SPHEM 2022 Conference

Retrieved on: 
Wednesday, August 17, 2022 - 3:01pm

TRUMBULL, Conn., Aug. 17, 2022 (GLOBE NEWSWIRE) -- ZetrOZ founder and CEO George Lewis, Ph.D., spoke at the annual PHATS (Professional Hockey Athletic Trainers Society) SPHEM (Society of Professional Hockey Equipment Managers) 2022 Conference, at the JW Marriott Marco Island Beach Resort in late June.

Key Points: 
  • TRUMBULL, Conn., Aug. 17, 2022 (GLOBE NEWSWIRE) -- ZetrOZ founder and CEO George Lewis, Ph.D., spoke at the annual PHATS (Professional Hockey Athletic Trainers Society) SPHEM (Society of Professional Hockey Equipment Managers) 2022 Conference, at the JW Marriott Marco Island Beach Resort in late June.
  • ZetrOZ Systems is a Platinum Sponsor of the PHATS/SPHEM 2022 Conference.
  • ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the southern coastal region of Connecticut.
  • ZetrOZ Systems produces UltrOZ, samSport, and samPro 2.0 to provide safe and effective treatment options for prevalent conditions such as arthritis.

Oyster Point Pharma Announces TYRVAYA® To Be Covered By the Largest Medicare Pharmacy Benefit Manager

Retrieved on: 
Wednesday, August 17, 2022 - 1:00pm

We are committed to growing patient access and are looking forward to continue engaging with Medicare Part D health plans.

Key Points: 
  • We are committed to growing patient access and are looking forward to continue engaging with Medicare Part D health plans.
  • Oyster Point Pharma is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases.
  • In October 2021, Oyster Point Pharma received FDA-approval for TYRVAYA (varenicline solution) Nasal Spray for the treatment of the signs and symptoms of dry eye disease.
  • Oyster Point Pharma has a growing pipeline of clinical and pre-clinical programs and continues to expand its research and development pipeline through internal innovation and external collaborations.

Growing Electric Vehicle Market Threatens to Short-Circuit Public Charging Experience, J.D. Power Finds

Retrieved on: 
Wednesday, August 17, 2022 - 1:00pm

Power U.S. Electric Vehicle Experience (EVX) Public Charging Study,SM released today.

Key Points: 
  • Power U.S. Electric Vehicle Experience (EVX) Public Charging Study,SM released today.
  • Not only is the availability of public charging still an obstacle, but EV owners continue to be faced with charging station equipment that is inoperable.
  • The National Electric Vehicle Infrastructure (NEVI) Formula Program promises to provide funds to states for building out their EV public charging infrastructure.
  • Public charger operability and maintenance a key issue: Growth of the public charging infrastructure is making it easier for EV owners to find public charging stations.

Parkinson's Foundation Invests $5.7 Million in Research Grants

Retrieved on: 
Tuesday, August 16, 2022 - 2:55pm

MIAMI and NEW YORK, Aug. 16, 2022 /PRNewswire/ -- The Parkinson's Foundation has announced an investment of $5.7 million in 33 grants to accelerate cutting-edge Parkinson's disease (PD) research. Through research grants, the Foundation funds scientists conducting innovative studies across various aspects of PD to bring forward new therapies, treatments and ultimately a cure for the 10 million people worldwide living with this debilitating neurological disease.

Key Points: 
  • MIAMI and NEW YORK, Aug. 16, 2022 /PRNewswire/ --The Parkinson's Foundation has announcedan investment of $5.7 million in 33 grants to accelerate cutting-edge Parkinson's disease (PD) research.
  • Through research grants, the Foundation funds scientists conducting innovative studies across various aspects of PD to bring forward new therapies, treatments and ultimately a cure for the 10 million people worldwide living with this debilitating neurological disease.
  • The Parkinson's Foundation makes life better for people with Parkinson's disease by improving care and advancing research toward a cure.
  • Since 1957, the Parkinson's Foundation has invested more than $400 million in Parkinson's research and clinical care.